Positive News SentimentPositive NewsNASDAQ:TKNO Alpha Teknova (TKNO) Stock Price, News & Analysis $5.18 -0.19 (-3.54%) Closing price 04:00 PM EasternExtended Trading$5.20 +0.02 (+0.41%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Alpha Teknova Stock (NASDAQ:TKNO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Alpha Teknova alerts:Sign Up Key Stats Today's Range$4.98▼$5.3450-Day Range$2.68▼$5.4052-Week Range$1.91▼$6.68Volume149,672 shsAverage Volume188,831 shsMarket Capitalization$277.72 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company Overview Alpha Teknova, Inc. (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications. The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations. Alpha Teknova also provides process development and scale-up manufacturing services for clients seeking tailored reagents or contract production, enabling seamless transition from bench-scale research to commercial-scale manufacturing. Headquartered in Hollister, California, Alpha Teknova serves a global customer base with sales and distribution channels across North America, Europe and Asia. Founded to streamline and enhance life science research, the company’s management team combines deep expertise in research, product development and commercial operations, positioning Alpha Teknova to address evolving needs in the biotechnology and pharmaceutical sectors.AI Generated. May Contain Errors. Read More Alpha Teknova Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreTKNO MarketRank™: Alpha Teknova scored higher than 63% of companies evaluated by MarketBeat, and ranked 361st out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingAlpha Teknova has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialAlpha Teknova has a consensus price target of $8.00, representing about 53.7% upside from its current price of $5.21.Amount of Analyst CoverageAlpha Teknova has only been the subject of 1 research reports in the past 90 days.Read more about Alpha Teknova's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Teknova is -16.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Teknova is -16.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Teknova has a P/B Ratio of 4.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Alpha Teknova's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.71% of the float of Alpha Teknova has been sold short.Short Interest Ratio / Days to CoverAlpha Teknova has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.Change versus previous monthShort interest in Alpha Teknova has recently decreased by 3.22%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlpha Teknova does not currently pay a dividend.Dividend GrowthAlpha Teknova does not have a long track record of dividend growth. News and Social Media4.3 / 5News SentimentN/A News SentimentAlpha Teknova has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Alpha Teknova this week, compared to 2 articles on an average week.Search Interest2 people have searched for TKNO on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Alpha Teknova to their MarketBeat watchlist in the last 30 days. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $55,900.00 in company stock, which represents 0.0200% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Alpha Teknova insiders have bought more of their company's stock than they have sold. Specifically, they have bought $55,900.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders12.50% of the stock of Alpha Teknova is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions13.81% of the stock of Alpha Teknova is held by institutions.Read more about Alpha Teknova's insider trading history. Receive TKNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TKNO Stock News HeadlinesAnalysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and REPRO-MED Systems (KRMD)May 9, 2026 | theglobeandmail.comAlpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their EstimatesMay 9, 2026 | finance.yahoo.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.June 2 at 1:00 AM | Porter & Company (Ad)Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comAlpha Teknova Charts Cautious Path to 2027 GrowthMay 7, 2026 | tipranks.comAlpha Teknova (TKNO) Q1 2026 Earnings TranscriptMay 6, 2026 | finance.yahoo.comTeknova Reports First Quarter 2026 Financial ResultsMay 6, 2026 | globenewswire.comTeknova to Report First Quarter 2026 Financial Results on May 6, 2026April 22, 2026 | globenewswire.comSee More Headlines TKNO Stock Analysis - Frequently Asked Questions How have TKNO shares performed this year? Alpha Teknova's stock was trading at $3.80 at the beginning of the year. Since then, TKNO shares have increased by 37.0% and is now trading at $5.2050. How were Alpha Teknova's earnings last quarter? Alpha Teknova, Inc. (NASDAQ:TKNO) released its earnings results on Wednesday, May, 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. The firm earned $11.08 million during the quarter, compared to the consensus estimate of $10.23 million. Alpha Teknova had a negative net margin of 41.07% and a negative trailing twelve-month return on equity of 24.32%. Read the conference call transcript. When did Alpha Teknova IPO? Alpha Teknova (TKNO) raised $90 million in an initial public offering on Thursday, June 24th 2021. The company issued 6,000,000 shares at a price of $14.00-$16.00 per share. Who are Alpha Teknova's major shareholders? Alpha Teknova's top institutional investors include Roubaix Capital LLC (3.51%), Bank of New York Mellon Corp (0.19%) and R Squared Ltd (0.03%). Insiders that own company stock include Telegraph Hill Partners Iv, L, J Matthew Mackowski, Stephen Gunstream, Matthew Lowell, Damon Terrill, Lisa Hood, Ken Gelhaus and Martha J Demski. View institutional ownership trends. How do I buy shares of Alpha Teknova? Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alpha Teknova own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alpha Teknova investors own include Myomo (MYO), Heron Therapeutics (HRTX), Taboola.com (TBLA), Ultralife (ULBI), NVIDIA (NVDA) and Sensus Healthcare (SRTS). Company Calendar Last Earnings5/06/2026Today6/02/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 TKNO's financial health is in the Green zone, according to TradeSmith. TKNO has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TKNO CIK1850902 Webwww.teknova.com Phone831-637-1100FaxN/AEmployees240Year Founded1996Price Target and Rating Average Price Target for Alpha Teknova$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+54.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$17.26 million Net Margins-41.07% Pretax Margin-40.87% Return on Equity-24.32% Return on Assets-16.34% Debt Debt-to-Equity Ratio0.20 Current Ratio4.59 Quick Ratio3.60 Sales & Book Value Annual Sales$41.80 million Price / Sales6.64 Cash FlowN/A Price / Cash FlowN/A Book Value$1.28 per share Price / Book4.05Miscellaneous Outstanding Shares53,614,000Free Float46,912,000Market Cap$277.72 million OptionableNot Optionable Beta0.62 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:TKNO) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredSecret behind near perfectly timed stock trades…?After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he ...Traders Agency | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredGold hit $4,500 - but these miners haven't caught up yet$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
